Christos Tzitzilonis

Christos Tzitzilonis has a diverse work experience in the field of protein sciences and molecular biology. Christos began their career as a Post Doctoral Fellow in Structural Biology at the Salk Institute for Biological Studies in 2005 and continued in this role until 2014. In 2014, they joined Genia Technologies - Roche as a Principal Research Scientist. After a year, they moved to REVOLUTION Medicines where they initially served as a Senior Scientist and later as a Senior Scientist II. In 2018, they joined Maze Therapeutics as a Senior Principal Scientist in Protein Sciences, focusing on Molecular Sciences. During their tenure at Maze Therapeutics, they also held positions as a Principal Scientist and Senior Scientist II in Protein Sciences, specifically in the area of drug discovery.

Christos Tzitzilonis attended The University of Manchester and obtained a Bachelor of Science (BSc) Honours degree in Biochemistry and Applied Molecular Biology. Christos further pursued their education at the same university and completed a Master in Philosophy (Mphil) degree in Biochemistry. Finally, they undertook a Doctor of Philosophy (PhD) program in Biochemistry, Biophysics, and Molecular Biology at The University of Manchester. The exact years of their educational pursuits are not provided.